跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 61,295 条关于
“indolent non-Hodgkin lymphoma”
全部
61,295
临床试验
47,708
药物
933
机构
138
资讯
12,516
去年
CAR-T Cell Therapy Shows Promise for Transformed Indolent Non-Hodgkin Lymphoma
去年
Real-World Study Validates Rituximab-Lenalidomide Efficacy in Indolent Non-Hodgkin Lymphoma Treatment
4个月前
Enterome's EO2463 Shows Promising CD8 T-Cell Expansion in Phase 2 Indolent Non-Hodgkin Lymphoma Trial
去年
Enterome Reports Positive Phase 2 Data for EO2463 in Indolent Non-Hodgkin Lymphoma
10个月前
Five-Year ZUMA-5 Data Shows Axicabtagene Ciloleucel Achieves Durable Responses in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
9个月前
ALX Oncology's Evorpacept Combination Achieves 92% Complete Response Rate in Frontline Indolent Non-Hodgkin Lymphoma Trial
去年
Enterome Secures $19 Million to Advance Novel OncoMimics Immunotherapy for Indolent Non-Hodgkin Lymphoma
3个月前
Enterome's EO2463 Receives FDA Orphan Drug Designation for Watch-and-Wait Indolent Non-Hodgkin Lymphoma
去年
Lenalidomide and Obinutuzumab Combination Shows Promise in Relapsed Non-Hodgkin Lymphoma
去年
European Commission Approves BMS's Breyanzi for Relapsed or Refractory Follicular Lymphoma
第 1 页，共 1252 页
上一页
下一页
